M8 Pharmaceuticals, an Acino company ('M8') announces that the company has signed an exclusive licensing agreement with Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) ('Supernus'), a biopharmaceutical ...
The UAE's reputation as an innovation center is well-earned. It is to these shores, more than any other in the region, that ...
The UK subsidiary of Japanese pharma major Takeda has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) for lanadelumab (trademarked Takhzyro) for the routine ...
Acino International (Acino), a pharmaceutical company headquartered in Switzerland with origins dating back to 1836 and manufacturing sites in five countries as well as commercial operations ...
ADQ’s shareholdings in three companies were transferred to Arcera: • Acino International (Acino), a pharmaceutical company headquartered in Switzerland with origins dating back to 1836 and ...
PARIS, March 20, 2024 /PRNewswire/ --M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a global specialty pharmaceutical company, are collaborating to bring an ...